HDL上调破骨细胞ABCG1表达从而影响破骨细胞生成并促进其凋亡
本文选题:HDL + ABCG1 ; 参考:《南华大学》2015年硕士论文
【摘要】:目的:胆固醇是细胞膜的主要组成部分,在破骨细胞的形成及生存中发挥重要作用。破骨细胞本身几乎不合成胆固醇,因此细胞内胆固醇容易失衡而影响破骨细胞形成或生存。研究发现HDL水平升高可促进破骨细胞胆固醇流出并促进其凋亡,但其促进胆固醇流出的机制及对破骨细胞形成的影响尚不清楚。本研究选取RAW264.7单核/巨噬细胞作为破骨前体细胞,以RANKL及M-CSF诱导其形成的破骨细胞为研究对象,探讨HDL促进破骨细胞胆固醇流出的机制及对其形成和生存的影响。方法:用含HDL的培养基培养RAW264.7细胞,加入RANKL及M-CSF刺激其分化形成破骨细胞,在不同的时间观察TRAP阳性的多核细胞的数目、大小和核固缩情况;用含不同浓度的HDL的培养基培养RAW264.7细胞,加入RANKL及M-CSF刺激其分化形成破骨细胞,液体闪烁计数仪检测其胆固醇流出情况;用含HDL的培养基培养RAW264.7细胞不同时间,加入RANKL及M-CSF刺激其分化形成破骨细胞,液体闪烁计数仪检测其胆固醇流出情况。HDL3、HDL2、Aop A1处理破骨细胞,观察其胆固醇流出情况及TRAP阳性的多核细胞的数目、大小和核固缩情况。用含HDL的培养基培养RAW264.7细胞3天,加入RANKL及M-CSF刺激其分化形成破骨细胞,荧光定量PCR检测破骨细胞ABCG1、SR-B1 m RNA的表达,Western blot检测ABCG1、SR-B1、Cav1蛋白表达。si RNA沉默ABCG1表达,观察其胆固醇流出情况及TRAP+的多核细胞的数目。结果:1)HDL处理细胞后,形成的破骨细胞最大直径减小,融合指数减小,核固缩的破骨细胞增多;2)HDL促进破骨细胞胆固醇流出,且呈浓度及时间依赖性,细胞内游离胆固醇明显减少;3)不同的HDL亚型促进破骨细胞胆固醇流出的能力不同,以HDL3能力最强;4)HDL处理使破骨细胞表达ABCG1增多而SR-B1减少;5)ABCG1 si RNA处理使HDL促进破骨细胞胆固醇流出的能力下降,破骨细胞形成恢复,凋亡减少;6)HDL处理使破骨细胞磷脂流出增多,Cav1表达减少。结论:HDL通过上调ABCG1的表达促进破骨细胞胆固醇流出,破坏破骨细胞内胆固醇平衡从而影响破骨细胞形成并促进其凋亡。
[Abstract]:Objective: cholesterol is a major component of cell membrane and plays an important role in the formation and survival of osteoclasts. The osteoclasts themselves almost do not synthesize cholesterol, so the cholesterol in the cells is easily out of balance and affects the formation or survival of osteoclasts. It was found that the increase of HDL level could promote cholesterol efflux and apoptosis of osteoclasts, but its mechanism of promoting cholesterol efflux and its effect on osteoclast formation were unclear. In this study, RAW264.7 mononuclear / macrophages were selected as osteoclasts, and RANKL and M-CSF induced osteoclasts were used to investigate the mechanism of HDL promoting cholesterol efflux of osteoclasts and their effects on the formation and survival of osteoclasts. Methods: RAW264.7 cells were cultured in HDL medium and stimulated by RANKL and M-CSF to form osteoclasts. The number, size and pyknosis of trap positive multinucleated cells were observed at different time points. RAW264.7 cells were cultured in a medium containing different concentrations of HDL. RANKL and M-CSF were added to stimulate the differentiation of RAW264.7 cells to form osteoclasts. The cholesterol efflux of RAW264.7 cells was detected by liquid scintillation counter, and RAW264.7 cells were cultured in HDL medium for different time. RANKL and M-CSF were added to stimulate the osteoclasts to differentiate into osteoclasts. The cholesterol efflux. HDL3 and HDL2Aop A1 were detected by liquid scintillation counter. The cholesterol efflux and the number, size and pyknosis of trap positive multinucleated cells were observed. RAW264.7 cells were cultured in HDL-containing medium for 3 days. RANKL and M-CSF were added to stimulate the osteoclasts to differentiate into osteoclasts. The expression of SR-B1 mRNA in osteoclasts was detected by fluorescence quantitative polymerase chain reaction (FQ-PCR). Western blot was used to detect the protein expression of RAW264.7 cells. Si RNA silenced ABCG1 expression. Cholesterol efflux and the number of polymorphonuclear cells in trap were observed. Results the maximum diameter and fusion index of osteoclasts were decreased, and the number of osteoclasts increased after treatment with HDL. The HDL promoted cholesterol outflow of osteoclasts in a concentration and time dependent manner. The ability of different HDL subtypes to promote cholesterol efflux of osteoclasts was different. HDL3 (4) HDL treatment increased the expression of ABCG1 in osteoclasts, while SR-B1 decreased the expression of ABCG1. 5) ABCG1si RNA treatment decreased the ability of HDL to promote cholesterol efflux of osteoclasts, and the formation of osteoclasts recovered. Apoptosis decreased 6) HDL treatment increased phospholipid efflux in osteoclasts and decreased the expression of Cav1. Conclusion by up-regulating the expression of ABCG1, VHDL can promote cholesterol efflux of osteoclasts, destroy the cholesterol balance in osteoclasts, and thus affect the formation of osteoclasts and promote the apoptosis of osteoclasts.
【学位授予单位】:南华大学
【学位级别】:硕士
【学位授予年份】:2015
【分类号】:R580
【参考文献】
相关期刊论文 前10条
1 黄新云;曹奇;唐朝克;;骨质疏松与动脉粥样硬化的相关性[J];中国动脉硬化杂志;2015年02期
2 黄喜顺;邱耀辉;吴义森;曾妍妍;;中老年人骨质疏松与颈动脉硬化斑块形成的关系初探[J];现代中西医结合杂志;2014年26期
3 宋美香;周晓辉;;老年高血压患者动脉硬化与骨质疏松的相关性[J];中国动脉硬化杂志;2014年04期
4 张娜;刘蕴玲;;骨桥蛋白与动脉粥样硬化和骨质疏松的关系[J];中国骨质疏松杂志;2012年10期
5 徐美林;张晓艳;张超;魏璇;;血清骨保护素与冠状动脉病变程度的关系研究[J];中华临床医师杂志(电子版);2012年13期
6 李晓涛;夏岳;郭喜朝;魏立业;戚国庆;;血浆骨桥蛋白水平与冠状动脉病变狭窄程度的关系研究[J];中国循环杂志;2011年04期
7 李传伟;陈玉成;曾智;;高密度脂蛋白亚型分布同冠心病关系的研究进展[J];心血管病学进展;2009年06期
8 侯建明;林庆明;李建卫;黄海燕;陈晓红;林杨;;老年人骨质疏松与主动脉硬化的相关性研究[J];中华骨质疏松和骨矿盐疾病杂志;2009年02期
9 许勇;杨桦;乔建瓯;李西华;严兰珍;王龙;徐国江;费俭;傅继粱;王铸钢;;骨保护素(Opg)基因敲除小鼠发生高转换型骨质疏松和动脉钙化(英文)[J];生物化学与生物物理进展;2007年03期
10 张永红;温进坤;韩梅;;抗骨桥蛋白抗体防治大鼠动脉粥样硬化的研究[J];中国老年学杂志;2007年01期
,本文编号:2115572
本文链接:https://www.wllwen.com/yixuelunwen/nfm/2115572.html